Your browser doesn't support javascript.
loading
Design, manufacturing and testing of a green non-isocyanate polyurethane prosthetic heart valve.
Melo, Sofia F; Nondonfaz, Alicia; Aqil, Abdelhafid; Pierrard, Anna; Hulin, Alexia; Delierneux, Céline; Ditkowski, Bartosz; Gustin, Maxime; Legrand, Maxime; Tullemans, Bibian M E; Brouns, Sanne L N; Nchimi, Alain; Carrus, Raoul; Dejosé, Astrid; Heemskerk, Johan W M; Kuijpers, Marijke J E; Ritter, Jan; Steinseifer, Ulrich; Clauser, Johanna C; Jérôme, Christine; Lancellotti, Patrizio; Oury, Cécile.
Afiliação
  • Melo SF; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Nondonfaz A; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Aqil A; Center for Education and Research on Macromolecules (CERM), CESAM Research Unit, Department of Chemistry, University of Liège, Allée du 6 août 13, B6a, 4000 Liège, Belgium.
  • Pierrard A; Center for Education and Research on Macromolecules (CERM), CESAM Research Unit, Department of Chemistry, University of Liège, Allée du 6 août 13, B6a, 4000 Liège, Belgium.
  • Hulin A; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Delierneux C; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Ditkowski B; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Gustin M; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Legrand M; Sirris, Liège Science Park, Rue du Bois Saint-Jean 12, 4102 Seraing, Belgium.
  • Tullemans BME; Cardiovascular Research Institute Maastricht (CARIM), Department of Biochemistry, Maastricht University, Universiteitssingel 50, 6200 MD Maastricht, The Netherlands.
  • Brouns SLN; Cardiovascular Research Institute Maastricht (CARIM), Department of Biochemistry, Maastricht University, Universiteitssingel 50, 6200 MD Maastricht, The Netherlands.
  • Nchimi A; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Carrus R; Sirris, Liège Science Park, Rue du Bois Saint-Jean 12, 4102 Seraing, Belgium.
  • Dejosé A; Sirris, Liège Science Park, Rue du Bois Saint-Jean 12, 4102 Seraing, Belgium.
  • Heemskerk JWM; Cardiovascular Research Institute Maastricht (CARIM), Department of Biochemistry, Maastricht University, Universiteitssingel 50, 6200 MD Maastricht, The Netherlands.
  • Kuijpers MJE; Cardiovascular Research Institute Maastricht (CARIM), Department of Biochemistry, Maastricht University, Universiteitssingel 50, 6200 MD Maastricht, The Netherlands.
  • Ritter J; Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen, Germany.
  • Steinseifer U; Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen, Germany.
  • Clauser JC; Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty RWTH Aachen University, Pauwelsstraße 20, 52074 Aachen, Germany.
  • Jérôme C; Center for Education and Research on Macromolecules (CERM), CESAM Research Unit, Department of Chemistry, University of Liège, Allée du 6 août 13, B6a, 4000 Liège, Belgium.
  • Lancellotti P; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
  • Oury C; Laboratory of Cardiology, GIGA-Cardiovascular Sciences, University of Liège, Avenue de l'Hôpital 11, B34, 4000 Liège, Belgium. cecile.oury@uliege.be.
Biomater Sci ; 12(8): 2149-2164, 2024 Apr 16.
Article em En | MEDLINE | ID: mdl-38487997
ABSTRACT
The sole effective treatment for most patients with heart valve disease is valve replacement by implantation of mechanical or biological prostheses. However, mechanical valves represent high risk of thromboembolism, and biological prostheses are prone to early degeneration. In this work, we aim to determine the potential of novel environmentally-friendly non-isocyanate polyurethanes (NIPUs) for manufacturing synthetic prosthetic heart valves. Polyhydroxyurethane (PHU) NIPUs are synthesized via an isocyanate-free route, tested in vitro, and used to produce aortic valves. PHU elastomers reinforced with a polyester mesh show mechanical properties similar to native valve leaflets. These NIPUs do not cause hemolysis. Interestingly, both platelet adhesion and contact activation-induced coagulation are strongly reduced on NIPU surfaces, indicating low thrombogenicity. Fibroblasts and endothelial cells maintain normal growth and shape after indirect contact with NIPUs. Fluid-structure interaction (FSI) allows modeling of the ideal valve design, with minimal shear stress on the leaflets. Injection-molded valves are tested in a pulse duplicator and show ISO-compliant hydrodynamic performance, comparable to clinically-used bioprostheses. Poly(tetrahydrofuran) (PTHF)-NIPU patches do not show any evidence of calcification over a period of 8 weeks. NIPUs are promising sustainable biomaterials for the manufacturing of improved prosthetic valves with low thrombogenicity.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poliuretanos / Próteses Valvulares Cardíacas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poliuretanos / Próteses Valvulares Cardíacas Idioma: En Ano de publicação: 2024 Tipo de documento: Article